Related references
Note: Only part of the references are listed.Why myc? An unexpected ingredient in the stem cell cocktail
Paul S. Knoepfler
CELL STEM CELL (2008)
Module map of stem cell genes guides creation of epithelial cancer stem cells
David J. Wong et al.
CELL STEM CELL (2008)
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Alexander Meissner et al.
NATURE BIOTECHNOLOGY (2007)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo et al.
NATURE REVIEWS CANCER (2007)
Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic Intraepithelial neoplasia, and adenocarcinoma: Association with Gleason score and chromosome 8p deletion
Carlise R. Bethel et al.
CANCER RESEARCH (2006)
A novel role of myosin VI in human prostate cancer
Thomas A. Dunn et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally et al.
CANCER CELL (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype
K Williams et al.
PROSTATE (2005)
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression
G Yang et al.
CANCER (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The life cycle of C-myc - From synthesis to degradation
RC Sears
CELL CYCLE (2004)
c-Myc localization within the nucleus: Evidence for association with the PML nuclear body
KP Smith et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Trefoil factor 3 overexpression in prostatic carcinoma: Prognostic importance using tissue microarrays
DA Faith et al.
PROSTATE (2004)
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
KP Porkka et al.
GENES CHROMOSOMES & CANCER (2004)
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
K Ellwood-Yen et al.
CANCER CELL (2003)
Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?
IV Litvinov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy
GJLH van Leenders et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer
N Tsuchiya et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer
O Saramaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Molecular genetics of prostate cancer
C Abate-Shen et al.
GENES & DEVELOPMENT (2000)
Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy
G van Leenders et al.
LABORATORY INVESTIGATION (2000)